Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Liaoning Innovative Drug R&D Engineering Center is a provincial-level research and development organization based in Shenyang, China, primarily affiliated with Shenyang Pharmaceutical University. Established to bridge the gap between academic discovery and industrial production, the center focuses on the development of novel anti-tumor agents and advanced drug delivery systems, including liposomal and nanoparticle formulations. It operates as a commercial entity providing contract research services, technical transfer, and preclinical evaluation for the pharmaceutical industry. The center has been instrumental in advancing several innovative small molecules and improved formulations through the Chinese regulatory pipeline. Its expertise is centered on oncology, leveraging deep academic ties to provide high-end pharmaceutical engineering solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovative Cancer Drug Research and Development Engineering Centre of Liaoning Province.